Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...

Jumping into the SaaS market without knowing who your customers are and what they actually need is like trying to sell ice to ...

As I’ve said before, passwords suck. Microsoft agrees—last year, it announced a goal of getting one billion users to embrace passkeys instead. As part of that effort, setting up a passkey for a ...

For Keegan-Michael Key, filming Only Murders in the Building was a career highlight. Speaking exclusively with PEOPLE at the ...

According to internet information statistics, the amount of data generated globally is expected to exceed 175ZB this year, ...

Opening week is in the books and while it was not the highest-scoring set of games, Sunday night's Baltimore Ravens-Buffalo Bills tilt was an instant classic. Then Minnesota Vikings QB J.J. McCarthy ...

In Week 1 a beat up San Francisco 49ers team managed to escape Lumen Field with a victory over the Seattle Seahawks. That outcome allowed the Niners to keep pace with the Los Angeles Rams and the ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...